REH ASX Week ended 07 Aug 2026

Weekly Investor Report

Reece Limited · Industrials · Industrial Distribution

Open interactive chart View report data
Latest close 17.30 AUD
7.5% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 17.7% above the Trend Line and sits at 98.6% of its 52-week range. The latest completed week returned 7.5%, after a 10.9% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is expensive relative to peers. The latest news-sentiment score is 50/100. Near-term considerations: price is close to its 52-week high.

Setup score 74 out of 100
Latest Close 17.30 AUD 7 Aug 2026
1W Return 7.5% latest completed week
4W Return 10.9% short-term follow-through
12W Return 30.0% quarterly tape
Trend Breadth 53.8% 28 of 52 weeks active
Volume Ratio 1.5x vs 13-week average
What is working
  • The trend backdrop is active with a 28-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Activity pressure is positive on the latest completed week.
  • Volume is elevated versus the 13-week average, confirming attention.
What could go wrong
  • Price is below Fair Value, so the market is still discounting the latest tape.
What to watch next
  • Price is close to its 52-week high; watch for continuation or exhaustion.
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 7.5% Latest completed week; four-week move 10.9%. Indicator stack 75/69 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Recent Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 50/100 3 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 17.7% above the Trend Line and sits at 98.6% of its 52-week range. The latest completed week returned 7.5%, after a 10.9% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.5x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.8512-week average 0.53

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure8/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.85Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 10.9% over four weeks, 30.0% over 12 weeks, and 24.1% over one year. The current trend has remained active for 28 consecutive weeks.

Performance by holding period

1W7.5%
4W10.9%
12W30.0%
26W21.2%
52W24.1%
Active trend streak28 weeks
Active weeks in one year28
Trend breadth53.8%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.06Latest activity-pressure read.
Pressure change2.7%Four-week change in activity pressure.
Leadership21.58Latest relative-leadership reading.
RS change26.2%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 30 Jun 2025 Field coverage 85% Model confidence 43%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength20/100Blend of value, momentum, and quality. Underlying universe rank 81; rank 1 is best.
Value9/100Relative valuation strength. Underlying universe rank 92; rank 1 is best.
Quality11/100Profitability and accounting quality. Underlying universe rank 90; rank 1 is best.
Momentum90/100Medium-term price momentum. Underlying universe rank 11; rank 1 is best.
Growth3/100Revenue and earnings growth. Underlying universe rank 98; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework4/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
33.6x
Price divided by trailing earnings.
Price / sales
1.2x
Market value relative to trailing revenue.
EV / EBITDA
14.3x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
2.8%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
28.5%
Gross profit retained from each unit of revenue.
Operating margin
2.1%
Operating profit retained from revenue.
Free-cash-flow margin
3.8%
Free cash flow generated from revenue.
Return on invested capital
2.5%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-1.4%
Latest one-year revenue growth.
EPS growth
-24.4%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-30.7%
Latest one-year free-cash-flow growth.
Piotroski F-score
4/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
1.0%
Cash dividends relative to market value.
Buyback yield
0.2%
Net share repurchases relative to market value.
Shareholder yield
1.2%
Dividend yield plus net buyback yield.
Net debt / EBITDA
2.0x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment50/100

Weighted news tone is neutral across 3 relevant articles.

0 positive · 3 neutral · 0 negative
Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-0.6%Distance below the 52-week high.
13-week volatility4.5%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher15 of 2611 weeks finished lower.
Best week+13.0%Week of 12 Jun.
Worst week-10.4%Week of 17 Apr.
Latest week+7.5%Week of 7 Aug.

Shape of recent returns

Strong gains7
Modest gains8
Flat weeks0
Modest losses5
Sharp losses6
Recent vol4.5%13-week weekly-return volatility.
Base vol6.2%52-week weekly-return volatility.
Up/down split29/23Count of positive and negative weeks in the 52-week window.
Average skew4.7% / -4.6%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

IndustryAU Industrial Distribution
4-week rank2 / 3
Group average8.5%
Trend breadth33.3%
Trend33.3%active weekly trend signals
MD100.0%positive activity pressure
RS66.7%positive relative leadership

Four-week leaders

CYG · ASX12.5%REH · ASX10.9%SGI · ASX2.0%
08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape70/100

Trend, activity pressure, participation, and risk combine to a 70/100 tape read.

 Indicator analysis82/100

Latest 12-week confirmation: trend 12/12, activity pressure 8/12, relative leadership 12/12.

Activity pressure 0.85; No reversal markers Factors29/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 9 SVQF4/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 248.0 of 257 Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks Sentiment50/100

Weighted news tone is neutral across 3 relevant articles.

Is There Now An Opportunity In Reece Limited (ASX:REH)? Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 202617.30 AUD7.5%14.70 AUD18.74 AUD1.0621.583.0MOn
31 Jul 202616.09 AUD1.6%14.58 AUD18.76 AUD0.9517.112.3MOn
24 Jul 202615.83 AUD-2.9%14.49 AUD18.77 AUD0.9518.323.0MOn
17 Jul 202616.31 AUD4.6%14.39 AUD18.79 AUD0.9321.992.0MOn
10 Jul 202615.60 AUD-5.1%14.27 AUD18.80 AUD1.0317.102.2MOn
3 Jul 202616.44 AUD-1.7%14.17 AUD18.82 AUD0.8823.22296.9KOn
26 Jun 202616.73 AUD3.2%14.03 AUD18.82 AUD0.5026.85667.6KOn
19 Jun 202616.21 AUD3.3%13.89 AUD18.83 AUD0.0822.433.0MOn
12 Jun 202615.69 AUD13.0%13.72 AUD18.84 AUD-0.3818.78424.0KOn
5 Jun 202613.89 AUD0.7%13.56 AUD18.86 AUD-0.667.162.4MOn
29 May 202613.80 AUD1.1%13.46 AUD18.88 AUD-0.674.841.1MOn
22 May 202613.65 AUD2.6%13.39 AUD18.91 AUD-0.644.273.0MOn
15 May 202613.31 AUD-1.5%13.33 AUD18.93 AUD-0.641.642.4MOn
8 May 202613.51 AUD-2.1%13.29 AUD18.96 AUD-0.611.312.7MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context